A bodycam video shared on X by @BrokenTruthTV shows a Florida Department of Children and Families (DCF) social worker removing 5-year-old Kenlee Zuraff from her mother, Joy Zuraff, in March 2024. Kenlee has cystic fibrosis (CF), a serious lung and digestive disease. The family and supporters call this “medical kidnapping” because they believe the state stepped in over disagreements about Kenlee’s medical care, especially her treatments.
In the video, the social worker says the mother did not give proper care. The worker also claims that two CF drugs—Trikafta and Orkambi—are “completely different drugs.” This statement is not accurate.
This video identifies falsehoods and misrepresentations by DCF in the Florida medical kidnapping of Kinlee Zuraff in Santa Rosa County, Florida. Orkambi and Trikafta both contain Ivacaftor as a shared active ingredient. #FreeKenlee pic.twitter.com/TMUPV4hw7K
— Broken Truth (@BrokenTruthTV) February 3, 2026
Accusations of Seeking Natural Remedies
The DCF accused Joy of looking for or preferring “natural remedies” instead of following recommended medical treatments. In the bodycam footage and related case descriptions, the social worker and DCF representatives portrayed the mother’s questions about certain drugs and her past use of alternative or adjusted regimens (like nebulized treatments) as refusal or non-compliance. Reports from the case highlight that doctors and DCF framed her hesitation over rapid switches to high-risk modulators as seeking less conventional options, leading to medical neglect claims. This contributed to the removal decision, with DCF emphasizing “refused treatments” tied to her concerns about side effects and desire for more data or second opinions.
Joy maintained she was providing consistent home care (including nebulized meds) but wanted careful consideration before adding new prescriptions with serious warnings.
Medications Kenlee Was On (As Referenced in the Video)
In the bodycam footage, Joy describes the treatments she was giving Kenlee at home to manage her CF. She lists several standard CF medications and nebulized therapies she was administering:
- Cayston (aztreonam) – an inhaled antibiotic for Pseudomonas infections.
- Levofloxacin (or “levavutrol” as phrased in dialogue) – another inhaled antibiotic.
- Cystiline sterile water (likely referring to hypertonic saline or sterile saline solutions for airway clearance).
- Other prior or adjusted nebulized treatments (she mentions switching from hypertonic saline to sterile water based on clinic guidance).
These are common CF airway clearance and infection-fighting therapies. Joy explained she was compliant with these but had concerns about adding or switching to CFTR modulators like Trikafta without full agreement, citing Kenlee’s past adverse events.
What Trikafta and Orkambi Really Are
Both drugs are made by Vertex Pharmaceuticals. They help fix problems in the CFTR protein (the main cause of CF in many people, especially those with the common F508del mutation).
- Orkambi mixes two parts: lumacaftor (helps move the broken protein to the cell surface) and ivacaftor (helps the protein open better to let chloride flow).
Orkambi Prescribing Information (Vertex) - Trikafta is a stronger “triple” drug: it adds elexacaftor and tezacaftor (extra helpers to fix and move the protein) plus ivacaftor (the same part as in Orkambi).
Trikafta Prescribing Information (FDA)
Ivacaftor is a main ingredient in both drugs. Official FDA and Vertex information confirms this. Trikafta usually works better for many patients—it improves breathing, lowers sweat salt levels more, and cuts down on lung flare-ups compared to Orkambi. But they are in the same family of medicines and share key parts.
Calling them “completely different” ignores this important connection.
Possible Risks and Warnings
Orkambi has been linked to side effects like higher liver enzymes (a sign of liver stress), breathing trouble, and eye lens changes (cataracts) in some children—often tied to ivacaftor.
Because Trikafta also has ivacaftor and works in a similar way, it can carry some of the same risks. Safety reports note possible liver enzyme rises and cataracts in kids on ivacaftor-based drugs like these.
Trikafta has a serious FDA boxed warning (the strongest type) for liver problems: “TRIKAFTA can cause serious and potentially fatal drug-induced liver injury. Cases of liver failure leading to transplantation and death have been reported in patients with and without a history of liver disease taking TRIKAFTA.” This can happen early (within a month) or later (up to 15 months). Doctors must check liver blood tests often—before starting, monthly for the first 6 months, then every 3 months for a year, and yearly after. Patients should stop the drug and call a doctor right away if they see signs like yellow skin/eyes, stomach pain on the right side, dark urine, nausea, or tiredness.
Trikafta Important Safety Information (Vertex)
These risks show why parents might carefully discuss treatments with doctors.
What the Cystic Fibrosis Foundation Says About Family Choices
The Cystic Fibrosis Foundation (CFF) stresses shared decision-making. Their guidelines say care decisions should combine doctor advice, the benefits and risks of treatments, the child’s unique needs, and the goals and preferences of the patient and family. This happens as a team effort between the family and clinicians.
For example, in guidelines for diagnosis, infant care, and adult care, the CFF repeats: “Care decisions regarding individual patients should be made using a combination of these recommendations, the associated benefit-risk assessment of treatment options from the clinical team, the patient’s individual and unique circumstances, as well as the goals and preferences of the patients and families that the team serves, as a part of shared decision-making between the patient and clinician.”
Clinical Care Guidelines (Cystic Fibrosis Foundation)
The Foundation sees parents as key partners in the care team, especially for kids. They support family-centered care where parents help create personalized plans.
Social Workers Are Not Doctors
Social workers help families in many ways—they connect people to resources, support emotional needs, and handle child welfare cases. But they are not medical experts. They do not go to medical school or train to decide on drugs, diagnoses, or treatment details.
The National Association of Social Workers (NASW) says social workers focus on family support and teamwork. For medical questions, they should work with real doctors, nurses, or specialists. In child protection cases, social workers gather information but depend on medical professionals for facts about medicines or health risks.
NASW Standards for Social Work Practice in Child Welfare
A social worker giving a firm opinion on drug differences can lead to mistakes in serious situations like child removal.
What’s Happening Now
Almost two years later, Joy Zuraff faces a Termination of Parental Rights (TPR) hearing on Monday, February 9, 2026, at the Santa Rosa County Courthouse in Milton, Florida (4025 Avalon Blvd, Milton, FL 32583). If approved, this would end Joy’s legal rights as Kenlee’s parent forever. DCF is pushing for it, even after firing the lead investigator in the case.
The hearing starts around 8:30 a.m.
Join the Prayer Vigil
On February 9, 2026, at 8:00 a.m., supporters plan a peaceful prayer vigil outside the courthouse. Everyone is welcome to come pray and show support for Joy and Kenlee. The goal is to let the court, lawyers, and DCF see that the family has community backing in their fight to reunite.
For more on the case, the full video, and how to help, visit FreeKenlee.com. Sharing this story, praying, and showing up peacefully can make a difference in this important moment.
Sources
- Orkambi Prescribing Information – Official Vertex Pharmaceuticals document detailing Orkambi’s composition, including ivacaftor as an active ingredient
- Trikafta Prescribing Information – FDA-approved label for Trikafta, confirming ivacaftor as a core component and detailing its mechanism and dosing
- Trikafta Important Safety Information – Vertex Pharmaceuticals page highlighting the boxed warning for serious liver injury and required liver monitoring
- Cystic Fibrosis Foundation Clinical Care Guidelines – Official CFF resource explaining shared decision-making and the central role of patients and families in treatment choices
- NASW Standards for Social Work Practice in Child Welfare – National Association of Social Workers guidelines outlining the scope of practice for social workers, emphasizing collaboration with medical professionals for health-related decisions
- FreeKenlee.com – Family support site with case updates, bodycam footage, background information, and ways to help Joy and Kenlee Zuraff
- Full Length Florida DCF Bodycam Article (Broken Truth) – Detailed coverage including transcript excerpts from the removal footage
